Alberto Barrientos Guzmán-rekin lankidetzan egindako argitalpenak (7)

2002

  1. Erythrocyte aminolevulinate dehydratase activity as a lead marker in patients with chronic renal failure

    American Journal of Kidney Diseases, Vol. 40, Núm. 1, pp. 43-50

1997

  1. Reduced aminolevulinic dehydrase activity with increased blood porphyrins in experimental chronic renal failure

    Experimental Nephrology, Vol. 5, Núm. 1, pp. 95-99

1996

  1. Abnormalities of Heme Biosynthesis in Experimental Acute Renal Failure

    Journal of the American Society of Nephrology, Vol. 7, Núm. 4, pp. 628-632

  2. Effects of recombinant human erythropoietin on porphyrin metabolism in uremic patients on hemodialysis

    Journal of the American Society of Nephrology, Vol. 7, Núm. 5, pp. 774-779

  3. Long-term erythropoietin in rats with reduced renal mass

    Nephron, Vol. 73, Núm. 2, pp. 280-285

1995

  1. Activation of the sympathetic nervous system in hemodialyzed patients treated with erythropoietin [8]

    Nephron

  2. Efficiency of three different hemodialysis membranes for plasma porphyrin removal

    American Journal of Kidney Diseases, Vol. 25, Núm. 1, pp. 30-33